Integrative and Complementary Therapy for Episodic Migraine and Tension-type Headache (NCT06764914) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Integrative and Complementary Therapy for Episodic Migraine and Tension-type Headache
130 participantsStarted 2025-01-01
Plain-language summary
This study is a monocentric uncontrolled observational study to evaluate a 12-14 day inpatient stay in an internal medicine clinic for integrative and complementary medicine for patients with episodic migraine and/or episodic tension headache. The aim is to investigate the extent to which a 14-day inpatient stay can influence a reduction in headache days and/or pain intensity, medication use, quality of life, anxiety, depression, perceived stress, general well-being, and a reduction in sick days/work absenteeism, and prevent the chronification of migraine and may counteract the chronification of migraine or tension-type headache. In addition, patients' previous experiences with complementary naturopathic therapies, expectations and perceived benefits in everyday life will be analysed.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Episodic migraine (\<15 headache days/month in the last 3 months)
* Episodic tension headache (\<15 headache days/month in the last 3 months)
* Mixed forms or parallel occurrence of both types of headache is permitted
* Diagnosis confirmed in advance by a neurologist
* Mandatory imaging to exclude another cause of headache before or during hospitalisation (cMRI or cCT)
* Participation in the integrative headache supply programm oft the health insurence provider Barmer Ersatzkasse and Techniker Krankenkasse
* Signed declaration of consent
Exclusion Criteria:
* Age younger than 18 years
* Chronic migraine (15 migraine days in the last 3 months) or chronic tension type headache
* Medication-induced headache/painkiller abuse (\> 10 triptans/combination analgesics/ergotamines/opiates or \>15 classical analgesics per month)
* Acute severe mental illness (e.g. severe depression with suicidal tendencies)
* Acute, severe physical illness that prevents participation in the inpatient naturopathic programme or emergency inpatient treatment of a different kind (e.g. ongoing treatment of a cancer severe acute illness of the cardiovascular system such as heart attack, stroke, acute insufficiency of other organs (kidney, liver, etc.), other severe acute neurological diseases, e.g. relapse of multiple sclerosis, uncontrolled epilepsy)
* Pregnancy/lactation period
* Simultaneous participation in other clinical studies
* No consent
What they're measuring
1
Number of headache days/month (headache diary);
Timeframe: 48 weeks after inpatient hospitalisation